Author:
Walker Gregory S.,Bauman Jonathan N.,Ryder Tim F.,Smith Evan B.,Spracklin Douglas K.,Obach R. Scott
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmaceutical Science,Pharmacology
Reference17 articles.
1. Drug Metabolites in Safety Testing
2. Biomimetic Chemical Catalysts in the Oxidative Activation of Drugs
3. Bruker Manual (2012) ERETIC 2 User’s Guide preliminary guide
4. Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing
5. Helal CJ, Chappie TA, and Humphrey JM. (2012) inventors, Pfizer, assignee. Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors. European Patent Office Application WO2012168817 A1. 2012 Dec 13.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献